https://www.selleckchem.com/pr....oducts/vafidemstat.h
Whereas TLR9 agonists are recognized as powerful stimulators of antitumor immunity, GM-CSF has had mixed reviews. In previously reported randomized trials we assessed the effects of local immune modulation in early-stage melanoma with CpG-B alone or with GM-CSF. Here we discuss the added value of GM-CSF and show sex-related differences. © 2019 The Author(s). Published with license by Taylor Francis Group, LLC.The term 'immunogenic cell death' (ICD) denotes an immunologically unique type of regulated cell death that enables, ra
Like
Comment
Share
